EXAGEN INC.

XGN

EXAGEN INC.

XGN

Insider Sentiment (TTM):

Last Purchase:2024-11-15Last Sale:2026-03-03Shares Purchased (TTM):0Shares Sold (TTM):80,965

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:8,731,356Shares Outstanding:23,854,997Institutional Ownership Pct.:36.60%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	25	22	32	36	30	11	22	22	24	27	36	28
Accounts Receivable Net Current	12	16	11	11	14	15	8	9	12	11	7	17
Prepaid Expense And Other Assets	-	6	6	6	7	7	7	4	5	4	5	3
Assets Current	43	44	49	53	51	33	36	36	41	42	48	49
Property Plant And Equipment And Finance Lease Rig…	-	7	7	7	5	5	5	5	5	5	5	7
Operating Lease Right Of Use Asset	2	1	1	2	2	2	2	3	3	3	3	4
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Assets	52	52	58	63	59	40	45	44	49	51	57	61
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	4	4	4	3	5	4	1	2	1	3	2
Accrued Liabilities Current	5	5	6	6	5	5	7	6	6	6	8	7
Contract With Customer Liability Current	1	1	1	1	1	1	1	-	-	-	-	-
Finance Lease Liability Current	-	1	1	1	-	-	0	-	-	-	-	-
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Long Term Debt Current	1	1	1	1	1	3	0	0	0	0	0	0
Liabilities Current	13	13	14	13	10	14	14	9	9	9	12	10
Long Term Debt Noncurrent	22	22	22	22	22	18	20	20	20	19	19	19
Finance Lease Liability Noncurrent	-	2	2	2	-	-	0	-	-	-	-	-
Operating Lease Liability Noncurrent	1	0	0	1	1	1	2	2	2	2	3	4
Other Liabilities Noncurrent	-	-	-	-	0	0	0	0	0	0	0	0
Liabilities	40	38	41	45	38	34	35	31	32	31	34	33
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	334	333	332	328	324	304	304	303	303	303	302	301
Retained Earnings Accumulated Deficit	-321	-318	-314	-310	-303	-298	-294	-291	-286	-283	-279	-274
Stockholders Equity	12	14	17	18	21	6	10	13	18	20	23	28
Liabilities And Stockholders Equity	52	52	58	63	59	40	45	44	49	51	57	61
Preferred Stock Number Of…
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	-	0	0	0	0	0	0	0	0	0
Common Stock Number Of Sh…
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	24	24	23	23	22	18	18	18	17	17	17	17
Shares Outstanding	24	24	23	23	22	18	18	18	17	17	17	17

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.79%	14.07%	13.82%	-	-	-	-	-	-	-	-	-
2025	11.20%	12.00%	16.32%	19.53%	13.14%	36.57%	-26.65%	-43.08%	-57.29%	-5.85%	-5.85%	53.23%
2024	23.17%	6.10%	24.39%	24.17%	30.83%	12.08%	63.08%	28.32%	43.37%	19.58%	78.64%	106.23%
2023	-	-	-	-6.59%	-11.36%	-44.69%	8.90%	30.82%	44.52%	-16.38%	-11.30%	14.12%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.18	3.47	3.45	4.08	4.95	2.32	2.70	4.05	4.32	4.83	4.02	4.83
Quick Ratio	3.18	3.47	3.45	4.08	4.95	2.32	2.70	4.05	4.32	4.83	4.02	4.83
Working Capital	29.40M	31.02M	34.73M	39.70M	40.69M	18.51M	22.95M	26.78M	31.35M	33.62M	35.94M	38.79M
Leverage & Debt
Debt to Equity	3.25	2.60	2.33	2.46	1.79	5.29	3.68	2.39	1.80	1.54	1.51	1.22
Interest Coverage TTM	-2.58	-2.80	-3.26	-3.51	-5.03	-6.28	-6.10	-6.88	-7.08	-8.07	-9.78	-13.44
Debt Ratio	0.76	0.72	0.70	0.71	0.64	0.84	0.79	0.70	0.64	0.61	0.60	0.55
Efficiency & Turnover
Asset Turnover TTM	1.29	1.48	1.30	1.20	1.09	1.25	1.09	1.07	1.00	0.86	0.73	0.64
Days Sales Outstanding TTM	68.46	81.40	51.23	58.77	80.53	82.46	47.19	86.52	89.99	66.16	43.86	97.87
Receivables Turnover TTM	5.33	4.48	7.12	6.21	4.53	4.43	7.74	4.22	4.06	5.52	8.32	3.73
Per Share Metrics
Diluted EPS TTM	-0.78	-0.85	-0.93	-0.83	-0.81	-0.84	-0.83	-0.93	-0.95	-1.08	-1.34	-1.84
Free Cash Flow Per Share TTM	-0.32	-0.59	-0.66	-0.01	-0.25	-0.83	-0.76	-0.32	-0.35	-0.80	-0.86	-1.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	58.64%	58.32%	58.28%	59.86%	59.42%	59.30%	59.51%	58.80%	59.13%	58.76%	56.06%	53.93%
Operating Profit Margin TTM	-18.58%	-20.65%	-21.13%	-19.62%	-23.85%	-24.68%	-24.51%	-27.62%	-27.90%	-32.54%	-43.46%	-62.34%
Net Profit Margin TTM	-26.61%	-29.49%	-29.97%	-29.94%	-28.85%	-27.34%	-27.17%	-30.36%	-30.56%	-34.74%	-45.08%	-62.90%
Growth Metrics
Net Revenue Growth (1Y)	20.83%	20.55%	19.65%	14.08%	3.89%	1.78%	5.89%	8.00%	7.05%	20.12%	15.33%	13.66%
Net Income Growth (1Y)	11.44%	30.04%	31.99%	12.48%	-1.93%	-19.91%	-36.19%	-47.87%	-50.74%	-56.79%	-50.01%	-19.00%
EPS Growth (1Y)	-2.76%	1.16%	11.45%	-10.50%	-15.45%	-22.55%	-38.03%	-49.47%	-52.16%	-57.79%	-51.70%	-21.80%
Valuation Metrics
P/E TTM	-5.94	-3.55	-6.57	-13.24	-8.67	-4.30	-4.94	-3.33	-1.91	-1.47	-1.49	-1.32
P/B TTM	9.20	4.96	7.51	13.90	7.00	10.40	7.82	4.38	1.88	1.43	1.55	1.56
P/S TTM	1.58	1.05	1.97	3.96	2.50	1.17	1.34	1.01	0.58	0.51	0.67	0.83
Market Cap	112.37M	71.56M	131.07M	252.12M	147.18M	66.62M	74.63M	56.41M	33.08M	28.53M	35.18M	42.82M
Enterprise Value	110.42M	73.84M	122.70M	240.34M	139.92M	76.17M	72.84M	54.43M	28.66M	20.60M	17.98M	33.62M
Calculated Values
Free Cash Flow TTM	-7.73M	-14.13M	-14.27M	-208.00K	-5.20M	-15.45M	-13.79M	-5.77M	-6.36M	-14.27M	-15.29M	-29.67M
Net Debt	-1.95M	2.27M	-8.38M	-11.78M	-7.26M	9.55M	-1.79M	-1.98M	-4.43M	-7.93M	-17.20M	-9.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-03Sale

Owner: Aballi, John

Title: President and CEO

Shares: 15,698

Price/Share: $3.62

Value: $56,826.76

Shares Owned: 687,299

Relationship: Director,Officer

Ownership: Direct

2026-02-24Sale

Owner: Aballi, John

Title: President and CEO

Shares: 11,430

Price/Share: $3.61

Value: $41,262.30

Shares Owned: 702,997

Relationship: Director,Officer

Ownership: Direct

2026-02-24Sale

Owner: Black, Jeffrey G.

Title: Chief Financial Officer

Shares: 1,584

Price/Share: $3.61

Value: $5,718.24

Shares Owned: 267,442

Relationship: Officer

Ownership: Direct

2025-10-16Sale

Owner: Aballi, John

Title: President and CEO

Shares: 31,787

Price/Share: $11.82

Value: $375,722.34

Shares Owned: 714,427

Relationship: Director,Officer

Ownership: Direct

2025-09-02Sale

Owner: Black, Jeffrey G.

Title: Chief Financial Officer

Shares: 20,466

Price/Share: $9.79

Value: $200,362.14

Shares Owned: 269,026

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-03	Aballi, John	Director,Officer	President and CEO	Direct	Sale	15,698	3.62	$56,826.76	687,299	4
2026-02-24	Aballi, John	Director,Officer	President and CEO	Direct	Sale	11,430	3.61	$41,262.30	702,997	4
2026-02-24	Black, Jeffrey G.	Officer	Chief Financial Officer	Direct	Sale	1,584	3.61	$5,718.24	267,442	4
2025-10-16	Aballi, John	Director,Officer	President and CEO	Direct	Sale	31,787	11.82	$375,722.34	714,427	4
2025-09-02	Black, Jeffrey G.	Officer	Chief Financial Officer	Direct	Sale	20,466	9.79	$200,362.14	269,026	4
2025-03-25	Nmsic, Co-Investment Fund…	TenPercentOwner	-	Indirect	Sale	350,000	3.30	$1,155,000.00	1,758,958	4
2024-11-20	Sun, Mountain Capital Par…	TenPercentOwner	-	Indirect	Sale	200,000	3.30	$660,000.00	2,108,958	4
2024-11-15	Black, Jeffrey G.	Officer	Chief Financial Officer	Direct	Purchase	22,298	2.98	$66,448.04	274,492	4
2024-11-14	Aballi, John	Director,Officer	President and CEO	Direct	Purchase	24,305	2.81	$68,297.05	689,799	4
2024-05-16	Aballi, John	Director,Officer	President and CEO	Indirect	Purchase	40,401	1.92	$77,569.92	40,401	4
2024-03-04	Adawi, Kamal	Officer	CFO and Corporate Secretary	Direct	Sale	12,784	1.91	$24,417.44	243,749	4
2024-02-06	Adawi, Kamal	Officer	CFO and Corporate Secretary	Direct	Sale	6,738	1.95	$13,139.10	181,533	4
2023-10-17	Aballi, John	Director,Officer	President and CEO	Direct	Sale	33,819	1.75	$59,183.25	415,984	4
2023-06-15	Tullis, Growth Fund Ii, L…	TenPercentOwner	-	Indirect	Purchase	167	3.11	$519.37	1,515,839	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

36.60%

Inst. Shares: 8,731,356

Shares Outstanding: 23,854,997

2025-12-31

47.69%

Inst. Shares: 10,281,319

Shares Outstanding: 21,558,245

2025-09-30

38.77%

Inst. Shares: 8,894,347

Shares Outstanding: 22,940,412

2025-06-30

43.17%

Inst. Shares: 9,102,190

Shares Outstanding: 21,085,749

2025-03-31

33.03%

Inst. Shares: 6,129,497

Shares Outstanding: 18,557,390

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	8,731,356	23,854,997	36.60%
2025-12-31	10,281,319	21,558,245	47.69%
2025-09-30	8,894,347	22,940,412	38.77%
2025-06-30	9,102,190	21,085,749	43.17%
2025-03-31	6,129,497	18,557,390	33.03%
2024-12-31	6,025,542	18,203,044	33.10%
2024-09-30	6,388,903	18,254,937	35.00%
2024-06-30	5,786,683	18,178,185	31.83%
2024-03-31	5,657,828	17,944,438	31.53%
2023-12-31	5,136,205	17,679,467	29.05%
2023-09-30	6,596,619	17,692,603	37.28%
2023-06-30	6,613,907	17,655,483	37.46%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

EXAGEN INC. (XGN) — SEC Financial Statements & Analysis

EXAGEN INC. (XGN) is a services-medical laboratories company, incorporated in DE. EXAGEN INC. trades on Nasdaq as: XGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), EXAGEN INC. reported a 20.83% year-over-year revenue growth, a Gross Profit Margin of 58.64% (TTM), a Debt-to-Equity ratio of 3.25x, a Price-to-Sales (P/S) ratio of 1.58x (TTM), a Price-to-Book (P/B) ratio of 9.20x (TTM), at a market cap of $112.37M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 20.83%
Gross Profit Margin TTM: 58.64%
Debt To Equity: 3.25x
P/S TTM: 1.58x
P/B TTM: 9.20x
Market Cap: $112.37M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is EXAGEN INC. in?

EXAGEN INC. (XGN) operates in the Services-Medical Laboratories industry.

What is XGN's market cap?

EXAGEN INC. (XGN) has a market capitalization of $112.37M as of 2026-06-30.

What exchange does XGN trade on?

EXAGEN INC. (XGN) trades on the Nasdaq.

Where is EXAGEN INC. incorporated?

EXAGEN INC. is incorporated in DE.

EXAGEN INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

EXAGEN INC. (XGN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.
Main Street's price.

EXAGEN INC. (XGN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.